PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
45.68
ESG score below 80% of AXSM's 59.55. Jim Chanos would check for potential ESG-related litigation and regulatory risks.
50.00
Environmental score 80-90% of AXSM's 55.69. Walter Schloss would scrutinize carbon exposure and transition planning.
39.02
Social score below 80% of AXSM's 63.57. Jim Chanos would check for potential social license and litigation risks.
48.01
Governance score 80-90% of AXSM's 59.38. Walter Schloss would scrutinize management accountability and board independence.